Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Ugo

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|December 8, 2009
[Polycytaemia vera]Valérie Ugo
Pathologie-Biologie|June 28, 2002
[New WHO classification of myelodysplastic syndromes. The consequences]Valérie Ugo
La Revue Du Praticien|January 25, 2007
[Polycythemia vera]Valérie Ugo
Pathologie-Biologie|June 28, 2002
[The place of growth factors in the treatment of myelodysplastic syndromes]Valérie Ugo, Nicole Casadevall
Medecine Sciences : M/S|June 30, 2005
[A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera]Valérie Ugo, Chloé James, William Vainchenker
Trends in Molecular Medicine|November 8, 2005
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsChloé James, Valérie Ugo, Nicole Casadevall, et al.
Bulletin Du Cancer|February 16, 2002
[Update on malignant hemopathies]Valérie Ugo, Ollivier Legrand, Alain Delmer, et al.
Thrombosis Research|July 27, 2010
Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasmsJérôme Duchemin, Valérie Ugo, Jean-Christophe Ianotto, et al.
Annals of Hematology|October 22, 2016
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohortJean-Christophe Ianotto, Aurélie Chauveau, Dominique Mottier, et al.
Annals of Hematology|October 14, 2015
Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinibDamien Luque Paz, Jean-Christophe Ianotto, Aurélie Chauveau, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|December 8, 2009
[Polycytaemia vera]Valérie Ugo
Pathologie-Biologie|June 28, 2002
[New WHO classification of myelodysplastic syndromes. The consequences]Valérie Ugo
La Revue Du Praticien|January 25, 2007
[Polycythemia vera]Valérie Ugo
Pathologie-Biologie|June 28, 2002
[The place of growth factors in the treatment of myelodysplastic syndromes]Valérie Ugo, Nicole Casadevall
Medecine Sciences : M/S|June 30, 2005
[A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera]Valérie Ugo, Chloé James, William Vainchenker
Trends in Molecular Medicine|November 8, 2005
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsChloé James, Valérie Ugo, Nicole Casadevall, et al.
Bulletin Du Cancer|February 16, 2002
[Update on malignant hemopathies]Valérie Ugo, Ollivier Legrand, Alain Delmer, et al.
Thrombosis Research|July 27, 2010
Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasmsJérôme Duchemin, Valérie Ugo, Jean-Christophe Ianotto, et al.
Annals of Hematology|October 22, 2016
JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohortJean-Christophe Ianotto, Aurélie Chauveau, Dominique Mottier, et al.
Annals of Hematology|October 14, 2015
Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinibDamien Luque Paz, Jean-Christophe Ianotto, Aurélie Chauveau, et al.
Pageof 7